Evidence map›Paper›PMID 20049094›Full record

ReviewDeutsches Arzteblatt international2009

Stem cells derived from cord blood in transplantation and regenerative medicine.

Verena Reimann, Ursula Creutzig, Gesine Kögler

Abstract readReview
In one paragraph

Review in Deutsches Arzteblatt international, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Knowledge about umbilical cord blood banking among Greek citizens.Blood transfusion = Trasfusione del sangue · 2014
    Article
  4. Viability and neural differentiation of mesenchymal stem cells derived from the umbilical cord following perinatal asphyxia.Journal of perinatology : official journal of the California Perinatal Association · 2012
    Article
  5. Article
  6. Stem cell applications in military medicine.Stem cell research & therapy · 2011
    Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Verena ReimannInstitut für Transplantationsdiagnostik und Zelltherapeutika, José Carreras Stammzellbank, Universitätsklinikum Düsseldorf, Düsseldorf, Germany. reimann@itz.uni-duesseldorf.de
Ursula Creutzig
Gesine Kögler

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPhysicians of any specialty may be the first persons to whom prospective parents turn for information about the acquisition and storage of stem cells derived from cord blood. Stem cells can potentially be used to treat many diseases, yet they are not a panacea. This article provides an overview of their current and possible future applications.

methodsOriginal papers were retrieved by a selective search of the literature, and the Internet sites and advertising brochures of private stem cell banks were also examined.

resultsAllogeneic hematopoietic stem cells derived from umbilical cord blood (obtained from healthy donors, rather than from the patient to be treated) have been in routine use worldwide for more than ten years in the treatment of hematopoietic diseases. Experiments in cell culture and in animal models suggest that these cells might be of therapeutic use in regenerative medicine, but also show that this potential can be realized only if the cells are not cryopreserved. There is as yet no routine clinical application of autologous hematopoietic stem cells from cord blood (self-donation of blood), even though cord blood has been stored in private banks for more than ten years.

conclusionsAutologous stem cells from cord blood have poor prospects for use in regenerative medicine, because they have to be cryopreserved until use. Physicians should tell prospective parents that they have no reason to feel guilty if they choose not to store cord blood in a private bank.

Indexed as

Fetal BloodBlood BanksBlood Transfusion, AutologousCord Blood Stem Cell TransplantationGermanyHumansRegenerative Medicineadult stem cellsallogeneic transplantationblood productshematopoietic stem cellsstemcell therapy

Identifiers

PMID20049094
PMCPMC2801068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.